Table 2.
Cox regression analysis of NAFLD related event incidence.
| Variable | HR (95% CI) | P value |
| All cases (n = 155) | ||
| Sex (M vs F) | 0.360 (0.049–2.650) | .316 |
| Age (≥60 vs <60 yr) | 6.38 (0.591–68.82) | .127 |
| Diabetes mellitus (+ vs -) | 2.17 (0.466–10.12) | .323 |
| Hyperlipidemia (+ vs -) | 0.977 (0.198–4.821) | .978 |
| FIB-4 index (≥0.07/yr vs <0.07/yr) | 0.969 (0.268–3.500) | .961 |
| Albumin (≥0.12g/dL/yr vs <0.12g/dL/yr) | 0.110 (0.022–0.551) | ∗∗.007 |
| Fibrosis (F3–4 vs F1–2) | 1.070 (0.191–5.992) | .939 |
| Prothrombin time (≥0.15%/yr vs <0.15%/yr) | 0.588 (0.126–2.747) | .499 |
| Selected only F3 to 4 cases (n = 34) | ||
| Sex (M vs F) | 23.3 (0.335–1625) | .146 |
| Age (≥60 vs <60 yr) | 34.1 (0.910–1277) | .056 |
| Diabetes mellitus (+ vs -) | 0.415 (0.032–5.399) | .502 |
| Hyperlipidemia (+ vs -) | 29.4 (0.835–1039) | .063 |
| FIB-4 index (≥0.07/yr vs <0.07/yr) | 1.027 (0.200–5.284) | .974 |
| Albumin (≥0.12g/dL/yr vs <0.12g/dL/yr) | 0.026 (0.001–0.460) | ∗.013 |
| Prothrombin time (≥0.15%/yr vs <0.15%/yr) | 0.103 (0.004–2.370) | .155 |